Prices And Availability Of Pharmaceuticals: Evidence From Nine Countries
- 1 January 2003
- journal article
- Published by Health Affairs (Project Hope) in Health Affairs
- Vol. 22 (Suppl1) , W3-521
- https://doi.org/10.1377/hlthaff.w3.521
Abstract
This study compares average price levels for pharmaceuticals in eight countries—Canada, Chile, France, Germany, Italy, Japan, Mexico, and the United Kingdom—relative to the United States. Our most comprehensive indexes, adjusted for U.S. manufacturer discounts, show Japan's prices to be higher than U.S. prices, and other countries' prices ranging from 6 percent to 33 percent lower than U.S. prices. The decline of the Canadian dollar and rise of the U.K. pound contribute to the finding of lower Canadian prices and higher U.K. prices in 1999 than in 1992. Our findings suggest that U.S.–foreign price differentials are roughly in line with income and smaller for drugs than for other medical services.Keywords
This publication has 3 references indexed in Scilit:
- Does Regulation Drive Out Competition in Pharmaceutical Markets?The Journal of Law and Economics, 2000
- Cross-national price differences for pharmaceuticals: how large, and why?Journal of Health Economics, 2000
- Price Discrimination for Pharmaceuticals: Welfare Effects in the US and the EUInternational Journal of the Economics of Business, 1997